| Module |
Time |
Title |
Duration |
Speaker |
| Introduction |
07:00-07:05 am |
Welcome, introduction & Opening Remarks |
5 min |
Andreia Albuquerque and Kimon Chatzistamatiou |
| Module 1 |
|
CERVIX |
|
Chairs: Kimon Chatzistamatiou, Siriwan Tangjitgamol |
|
07:05-07:20 am |
HPV infection. Natural history and Cervical carcinogenesis – CIN |
15 min |
John Doorbar |
|
07:20-07:35 am |
HPV-based screening. Risk-based referral to colposcopy. Differences between LMICs and HICs. |
15 min |
Nicolas Wentzensen |
|
07:35-07:50 am |
Cervical cancer prevention in WLWH (considerations for screening and HPV vaccination) |
15 min |
Marc Steben |
|
07:50-08:05 am |
Cervical treatment decision-making (CIN2 surveillance, choice of treatment, post-op HPV vaccination) |
15 min |
Maria Kyrgiou |
|
08:05-08:20 am |
Basic principles of colposcopy / cervical biopsy – endocervical curretage (setting, tools, technique) |
15 min |
Maggie Cruickshank |
|
08:20-08:35 am |
Break |
15 min |
|
|
08:35-08:50 am |
LLETZ (setting, tools, technique) |
15 min |
Sarah Feldman |
|
08:50-09:05 am |
Laser Conisation – Cold knife Conization (setting, tools, technique) |
15 min |
Murat Gutelkin |
|
09:05-09:20 am |
Ablative procedures (thermocoagulation) |
15 min |
Wendy McMullen |
|
09:20- 09:35 am |
Discussion |
15 min |
All |
|
09:35-09:55 am |
Case-based discussion |
20 min |
All |
|
09:55-10:10 am |
Break |
15 min |
|
| Module 2 |
|
ANUS |
|
Chairs: Andreia Albuquerque and Isabelle Etienney |
|
10:10-10:25 am |
Epidemiology of anal HPV infection and anal HPV-related diseases: high-risk women in the spotlight |
15 min |
Ashish Deshmukh |
|
10:25-10:40 am |
Recommendations for anal cancer screening: what is new and what is missing |
15 min |
Andreia Albuquerque |
|
10:40-10:55 am |
Principles and quality in high-resolution anoscopy |
15 min |
Richard Hillman |
|
10:55-11:10 am |
From a Pathologist to a Clinician: how to interpret histology and biomarkers |
15 min |
Diego Guillen |
|
11:10-11:25 am |
From a Epidemiologist to a Clinician: how to improve primary prevention |
15 min |
Ann Burchell |
|
11:25-11:40 am |
Break |
15 min |
|
|
11:40-11:55 am |
Options and overcoming limitations of anal precancerous lesions treatment |
15 min |
Joel Palefky |
|
11:55 am-12:10 pm |
Challenging clinical situations: extensive disease, women with multizonal disease, transgender people |
15 min |
Carmela Cappello |
|
12:10-12:25 pm |
Discussion |
15 min |
All |
|
12:25-12:45 pm |
Case-based discussion |
20 min |
Richard Hillman, Isabelle Etienney |
|
12:45-01:30 pm |
Lunch Break |
45 min |
|
| Module 3 |
|
VULVA |
|
Chairs: Jacob Bornstein, Pedro Vieira Baptista |
|
01:30-01:45 pm |
Vulvar cancer screening: when to do it |
15 min |
Mario Preti |
|
01:45-02:00 pm |
Treatment options for vulvar precancerous lesions |
15 min |
Mario Preti |
|
02:00-02:15 pm |
HPV vaccine to prevent vulvar HPV-associated diseases |
15 min |
Pedro Vieira Baptista |
|
02:15-02:30 pm |
Discussion |
15 min |
All |
|
02:30-02:45 pm |
Break |
15 min |
|
| Round table |
|
Round table: difficult situations in the daily clinical practice |
|
Chairs: Sarah Feldman, Wichai Termrungruanglert |
|
02:45-03:00 pm |
How to talk about HPV with patients: answering frequent questions |
15 min |
Pedro Vieira Baptista |
|
03:00-03:15 pm |
How to deal with HPV vaccine misinformation and fake news |
15 min |
Jacob Bornstein |
|
03:15-03:30 pm |
Breaking bad news: cancer |
15 min |
Abigail Ribeiro |
|
03:30-03:40 pm |
Discussion |
10 min |
All |
| Closing |
03:40-03:45 pm |
Closing remarks |
5 min |
Andreia Albuquerque and Kimon Chatzistamatiou |